← Back to Clinical Trials
Recruiting NCT06589128

NCT06589128 Efficacy of Investigator Product for the Amelioration of Digital Eye Strain in Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06589128
Status Recruiting
Phase —
Sponsor Universiti Sains Malaysia
Condition Digital Eye Strain (DES)
Study Type INTERVENTIONAL
Enrollment 70 participants
Start Date 2024-10-01
Primary Completion 2025-10-25

Eligibility & Interventions

Sex All sexes
Min Age 10 Years
Max Age 11 Years
Study Type INTERVENTIONAL
Interventions
Astaxanthin Oral CapsulePlacebo

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 70 participants in total. It began in 2024-10-01 with a primary completion date of 2025-10-25.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Computer vision syndrome (CVS), also referred to as Digital eye strain (DES), is a group of eye and vision problems caused by prolonged use of electronic devices. The American Optometric Association (APA) defines DES as a group of eye and vision-related problems caused by prolonged computer, tablet, e-reader, and cell phone use. Currently, for more than 20 years, DES has been recognised as a public health issue, and the terms DES are also used to describe the condition, attributed to the wide range of digital devices associated with potential problems.

Eligibility Criteria

Inclusion Criteria: * Children with DES (CVS-Q score 6-18) Exclusion Criteria: * Children with CVS-Q score ≥ 19 * Children who wear contact lenses * Children with any diagnosed ocular motility disorder or accommodative/binocular vision issues * Participants who are colour-blind * Participant on any retinols and carotenoid supplements * Participants who have immunosuppressive disorders or are taking immunosuppressive medication * Atopy, allergic disorders * Anaemia * Ophthalmic laser treatment (less than 3 months) * Systemic disease associated with dry eye * Blepharitis * Having liver (chronic liver failure, cirrhosis, all types of hepatitis), kidney (chronic kidney disease, haemodialysis) or haematological (anaemia, thalassemia, haemophilia) disorders * Psychiatric disease/mental retardation (bipolar disorder, depression, schizophrenia) * Cancer (all types), and endocrine disorders (Cushing's disease, gigantism and hyperthyroidism) * Use of steroids, chemotherapy or radiotherapy * Currently under another supplementary program

Contact & Investigator

Central Contact

Lai Kuan Lee, PhD

✉ l.k.lee@usm.my

📞 6046536360

Principal Investigator

Lai Kuan Dr., PhD

PRINCIPAL INVESTIGATOR

Universiti Sains Malaysia

Frequently Asked Questions

Who can join the NCT06589128 clinical trial?

This trial is open to participants of all sexes, aged 10 Years or older, up to 11 Years, studying Digital Eye Strain (DES). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06589128 currently recruiting?

Yes, NCT06589128 is actively recruiting participants. Contact the research team at l.k.lee@usm.my for enrollment information.

Where is the NCT06589128 trial being conducted?

This trial is being conducted at Kepala Batas, Malaysia, Kepala Batas, Malaysia.

Who is sponsoring the NCT06589128 clinical trial?

NCT06589128 is sponsored by Universiti Sains Malaysia. The principal investigator is Lai Kuan Dr., PhD at Universiti Sains Malaysia. The trial plans to enroll 70 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology